1. Home
  2. PTCT
  3. PTCT News

Latest PTC Therapeutics Inc. (PTCT) News on November 25, 2024

FDA Grants Conditional Approval For PTC Therapeutics' Gene Therapy As First Ever With Direct Administration In Brain
PTCT

Benzinga

10 days ago

FDA Grants Conditional Approval For PTC Therapeutics' Gene Therapy As First Ever With Direct Administration In Brain

FDA grants accelerated approval for PTC’s AADC deficiency gene therapy
PTCT

Pharmaceutical Technology

11 days ago

FDA grants accelerated approval for PTC’s AADC deficiency gene therapy

PTCT

MT Newswires

11 days ago

Sector Update: Health Care Stocks Advance Pre-Bell Thursday

PTC wins US approval of gene therapy for fatal enzyme disorder
PTCT

BioPharma Dive

11 days ago

PTC wins US approval of gene therapy for fatal enzyme disorder

PTCT

MT Newswires

11 days ago

PTC Therapeutics Receives FDA Acceslerated Approval for Rare Brain Disease Deficiency Treatment

PTC Therapeutics Announces FDA Approval of AADC Deficiency Gene Therapy
PTCT

PR Newswire

11 days ago

PTC Therapeutics Announces FDA Approval of AADC Deficiency Gene Therapy

PTC Therapeutics Third Quarter 2024 Earnings: Beats Expectations
PTCT

Simply Wall St.

16 days ago

PTC Therapeutics Third Quarter 2024 Earnings: Beats Expectations

PTC Therapeutics Inc (PTCT) Q3 2024 Earnings Call Highlights: Revenue Growth and Strategic ...
PTCT

GuruFocus.com

17 days ago

PTC Therapeutics Inc (PTCT) Q3 2024 Earnings Call Highlights: Revenue Growth and Strategic ...

PTC Therapeutics (PTCT) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
PTCT

Zacks

17 days ago

PTC Therapeutics (PTCT) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

PTC Therapeutics (PTCT) Reports Q3 Loss, Tops Revenue Estimates
PTCT

Zacks

17 days ago

PTC Therapeutics (PTCT) Reports Q3 Loss, Tops Revenue Estimates

PTCT

Associated Press Finance

17 days ago

PTC Therapeutics: Q3 Earnings Snapshot

PTC Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results
PTCT

PR Newswire

17 days ago

PTC Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results

Unlocking Q3 Potential of PTC Therapeutics (PTCT): Exploring Wall Street Estimates for Key Metrics
PTCT

Zacks

19 days ago

Unlocking Q3 Potential of PTC Therapeutics (PTCT): Exploring Wall Street Estimates for Key Metrics

PTC Therapeutics Inc (PTCT) Q3 2024: Everything You Need To Know Ahead Of Earnings
PTCT

GuruFocus.com

19 days ago

PTC Therapeutics Inc (PTCT) Q3 2024: Everything You Need To Know Ahead Of Earnings

PTC Therapeutics to Participate at Upcoming Investor Conferences
PTCT

PR Newswire

20 days ago

PTC Therapeutics to Participate at Upcoming Investor Conferences

Regeneron battles Wall Street uncertainty; Madrigal extends fast launch of MASH drug
PTCT

BioPharma Dive

24 days ago

Regeneron battles Wall Street uncertainty; Madrigal extends fast launch of MASH drug

PTCT

MT Newswires

a month ago

PTC Therapeutics New Drug Application Resubmission for Translarna Accepted for FDA Review

PTC Therapeutics (NASDAQ:PTCT) grows 8.1% this week, taking one-year gains to 127%
PTCT

Simply Wall St.

a month ago

PTC Therapeutics (NASDAQ:PTCT) grows 8.1% this week, taking one-year gains to 127%

PTC Therapeutics Announces FDA Acceptance of Translarna™ NDA Resubmission
PTCT

PR Newswire

a month ago

PTC Therapeutics Announces FDA Acceptance of Translarna™ NDA Resubmission

PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PTCT

PR Newswire

a month ago

PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

PTC Therapeutics to Host Conference Call to Discuss Third Quarter 2024 Financial Results
PTCT

PR Newswire

a month ago

PTC Therapeutics to Host Conference Call to Discuss Third Quarter 2024 Financial Results

Analysts Estimate Stevanato Group (STVN) to Report a Decline in Earnings: What to Look Out for
PTCT

Zacks

a month ago

Analysts Estimate Stevanato Group (STVN) to Report a Decline in Earnings: What to Look Out for

State Street Corp's Strategic Acquisition in PTC Therapeutics Inc
PTCT

GuruFocus.com

a month ago

State Street Corp's Strategic Acquisition in PTC Therapeutics Inc

PTCT

MT Newswires

a month ago

PTC Therapeutics Says EU Regulator Maintained Negative Opinion on Translarna Marketing Renewal

PTC rebuffed again by EMA; Novartis licenses China-based biotech’s cancer drug
PTCT

BioPharma Dive

a month ago

PTC rebuffed again by EMA; Novartis licenses China-based biotech’s cancer drug

CHMP Maintains Negative Opinion on Translarna™ Reexamination
PTCT

PR Newswire

a month ago

CHMP Maintains Negative Opinion on Translarna™ Reexamination

Will PTC Therapeutics (PTCT) Report Negative Q3 Earnings? What You Should Know
PTCT

Zacks

a month ago

Will PTC Therapeutics (PTCT) Report Negative Q3 Earnings? What You Should Know

PTCT

MT Newswires

a month ago

PTC Therapeutics Gets FDA Drug Review Date for Phenylketonuria Treatment

PTC Therapeutics Announces FDA Target Regulatory Action Date for Sepiapterin and Lancet Publication of Phase 3 Trial Results
PTCT

PR Newswire

a month ago

PTC Therapeutics Announces FDA Target Regulatory Action Date for Sepiapterin and Lancet Publication of Phase 3 Trial Results

PTC Therapeutics Inc (PTCT) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and ...
PTCT

GuruFocus.com

2 months ago

PTC Therapeutics Inc (PTCT) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and ...

PTC Therapeutics (PTCT) Surges 16.5%: Is This an Indication of Further Gains?
PTCT

Zacks

2 months ago

PTC Therapeutics (PTCT) Surges 16.5%: Is This an Indication of Further Gains?

PTCT Stock Rises on Positive Updates on Friedreich Ataxia Program
PTCT

Zacks

2 months ago

PTCT Stock Rises on Positive Updates on Friedreich Ataxia Program

PTCT

MT Newswires

2 months ago

Sector Update: Health Care Stocks Rise Late Afternoon

PTCT

MT Newswires

2 months ago

Sector Update: Health Care Stocks Edge Higher Tuesday Afternoon

PTCT

MT Newswires

2 months ago

Update: PTC Therapeutics Reports 'Positive' Updates on Neurodegenerative Disorder Treatment Candidate; Shares Jump

PTCT

MT Newswires

2 months ago

PTC Therapeutics Reports 'Positive' Updates on Neurodegenerative Disorder Treatment Candidate; Shares Jump

PTC Therapeutics Announces Positive Results from Long-Term Treatment Studies and Updates on Regulatory Progress for Vatiquinone Friedreich Ataxia Program
PTCT

PR Newswire

2 months ago

PTC Therapeutics Announces Positive Results from Long-Term Treatment Studies and Updates on Regulatory Progress for Vatiquinone Friedreich Ataxia Program

PTCT

MT Newswires

2 months ago

RBC Lifts Price Target on PTC Therapeutics to $34 From $32, Keeps Sector Perform Rating

3 Top Stocks That Could Still Rocket Higher in 2024
PTCT

Motley Fool

2 months ago

3 Top Stocks That Could Still Rocket Higher in 2024

PTCT

MT Newswires

2 months ago

PTC Therapeutics' New Drug Application for Phenylketonuria Treatment Sepiapterin Gets Accepted by FDA

PTC Therapeutics Announces FDA Acceptance for Filing of NDA for Sepiapterin for the Treatment of Pediatric and Adult Phenylketonuria Patients
PTCT

PR Newswire

2 months ago

PTC Therapeutics Announces FDA Acceptance for Filing of NDA for Sepiapterin for the Treatment of Pediatric and Adult Phenylketonuria Patients

5 FDA decisions to watch in the fourth quarter
PTCT

BioPharma Dive

2 months ago

5 FDA decisions to watch in the fourth quarter

PTCT

MT Newswires

2 months ago

PTC Therapeutics Granted FDA Fast Track Designation for Huntington's Disease Program

FDA Grants Fast Track Designation to PTC518 Huntington's Disease Program
PTCT

PR Newswire

2 months ago

FDA Grants Fast Track Designation to PTC518 Huntington's Disease Program

PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PTCT

PR Newswire

2 months ago

PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

PTC Therapeutics to Participate at Upcoming Investor Conferences
PTCT

PR Newswire

3 months ago

PTC Therapeutics to Participate at Upcoming Investor Conferences

PTCT

MT Newswires

3 months ago

ClearPoint Neuro Repays $10 Million Convertible Note Early

PTCT

MT Newswires

3 months ago

PTC Therapeutics Has Upside Potential With Multiple Upcoming Catalysts, UBS Says

PTCT

MT Newswires

3 months ago

UBS Upgrades PTC Therapeutics to Buy From Neutral, $47 Price Target

PTC Therapeutics Stock Earns RS Rating Upgrade To 83
PTCT

Investor's Business Daily

3 months ago

PTC Therapeutics Stock Earns RS Rating Upgrade To 83

PTC Therapeutics Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
PTCT

Simply Wall St.

3 months ago

PTC Therapeutics Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

PTC Therapeutics (PTCT) Reports Q2 Loss, Misses Revenue Estimates
PTCT

Zacks

4 months ago

PTC Therapeutics (PTCT) Reports Q2 Loss, Misses Revenue Estimates

PTCT

Associated Press Finance

4 months ago

PTC Therapeutics: Q2 Earnings Snapshot

PTC Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial Results
PTCT

PR Newswire

4 months ago

PTC Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial Results

Unlocking Q2 Potential of PTC Therapeutics (PTCT): Exploring Wall Street Estimates for Key Metrics
PTCT

Zacks

4 months ago

Unlocking Q2 Potential of PTC Therapeutics (PTCT): Exploring Wall Street Estimates for Key Metrics

Crinetics Pharmaceuticals, Inc. (CRNX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
PTCT

Zacks

4 months ago

Crinetics Pharmaceuticals, Inc. (CRNX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

PTCT

MT Newswires

4 months ago

PTC Therapeutics Submits New Drug Application to US FDA for Metabolic Disorder Treatment

PTC Therapeutics Announces Sepiapterin NDA Submission to FDA
PTCT

PR Newswire

4 months ago

PTC Therapeutics Announces Sepiapterin NDA Submission to FDA

PTC Therapeutics to Host Conference Call to Discuss Second Quarter 2024 Financial Results
PTCT

PR Newswire

4 months ago

PTC Therapeutics to Host Conference Call to Discuss Second Quarter 2024 Financial Results

Will PTC Therapeutics (PTCT) Report Negative Q2 Earnings? What You Should Know
PTCT

Zacks

4 months ago

Will PTC Therapeutics (PTCT) Report Negative Q2 Earnings? What You Should Know

PTCT

MT Newswires

5 months ago

RBC Cuts Price Target on PTC Therapeutics to $32 From $39, Keeps Sector Perform Rating

PTCT

MT Newswires

5 months ago

Cantor Fitzgerald Raises Price Target on PTC Therapeutics to $62 From $52, Maintains Overweight Rating

PTC Therapeutics (PTCT) Down on Negative CHMP Opinion on DMD Drug
PTCT

Zacks

5 months ago

PTC Therapeutics (PTCT) Down on Negative CHMP Opinion on DMD Drug

PTC's Journey Of 'Twist And Doubt' Continues With Another Rejection; Shares Tumble
PTCT

Investor's Business Daily

5 months ago

PTC's Journey Of 'Twist And Doubt' Continues With Another Rejection; Shares Tumble

PTCT

MT Newswires

5 months ago

Update: PTC Therapeutics Shares Drop After Negative Opinion on Muscular Dystrophy Treatment

PTC Therapeutics Tumbles After European Regulators Reject Its Drug — Again
PTCT

Investor's Business Daily

5 months ago

PTC Therapeutics Tumbles After European Regulators Reject Its Drug — Again

PTC faces another Duchenne drug rejection; Coherus sells Humira biosimilar
PTCT

BioPharma Dive

5 months ago

PTC faces another Duchenne drug rejection; Coherus sells Humira biosimilar

PTCT

MT Newswires

5 months ago

PTC Therapeutics Shares Drop After Negative Opinion on Muscular Dystrophy Treatment

CHMP Issues Negative Opinion on Translarna™ Following European Commission Request for Review
PTCT

PR Newswire

5 months ago

CHMP Issues Negative Opinion on Translarna™ Following European Commission Request for Review

PTC Therapeutics (PTCT) Soars 9.7%: Is Further Upside Left in the Stock?
PTCT

Zacks

5 months ago

PTC Therapeutics (PTCT) Soars 9.7%: Is Further Upside Left in the Stock?

PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PTCT

PR Newswire

5 months ago

PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

PTCT

MT Newswires

5 months ago

BofA Securities Adjusts PTC Therapeutics Price Target to $32 From $25, Maintains Underperform Rating

PTCT

MT Newswires

5 months ago

PTC Therapeutics Reports Favorable Interim Results in Huntington's Disease Study; US FDA Lifts Clinical Hold

FDA lifts hold on PTC Huntington’s disease trial
PTCT

BioPharma Dive

5 months ago

FDA lifts hold on PTC Huntington’s disease trial

Interim PIVOT-HD Results Demonstrate Evidence of Favorable CNS Biomarker and Clinical Effects at Month 12 in Huntington's Disease Patients
PTCT

PR Newswire

5 months ago

Interim PIVOT-HD Results Demonstrate Evidence of Favorable CNS Biomarker and Clinical Effects at Month 12 in Huntington's Disease Patients

PTC Therapeutics to Participate at Upcoming Investor Conference
PTCT

PR Newswire

6 months ago

PTC Therapeutics to Participate at Upcoming Investor Conference

PTC Therapeutics Announces Validation of Sepiapterin European MAA
PTCT

PR Newswire

6 months ago

PTC Therapeutics Announces Validation of Sepiapterin European MAA

Insider Sale: Director Jerome Zeldis Sells 20,000 Shares of PTC Therapeutics Inc (PTCT)
PTCT

GuruFocus.com

6 months ago

Insider Sale: Director Jerome Zeldis Sells 20,000 Shares of PTC Therapeutics Inc (PTCT)

PTCT

MT Newswires

6 months ago

Ptc Therapeutics Insider Sold Shares Worth $764,800, According to a Recent SEC Filing

The Zacks Analyst Blog Highlights Biogen, Ionis Pharmaceuticals, GSK, PTC Therapeutics and Larimar Therapeutics
PTCT

Zacks

6 months ago

The Zacks Analyst Blog Highlights Biogen, Ionis Pharmaceuticals, GSK, PTC Therapeutics and Larimar Therapeutics

Biotech Stock Roundup: BIIB's Acquisition, PTCT, LRMR Gain on Updates & More News
PTCT

Zacks

6 months ago

Biotech Stock Roundup: BIIB's Acquisition, PTCT, LRMR Gain on Updates & More News

News Flash: Analysts Just Made A Notable Upgrade To Their PTC Therapeutics, Inc. (NASDAQ:PTCT) Forecasts
PTCT

Simply Wall St.

6 months ago

News Flash: Analysts Just Made A Notable Upgrade To Their PTC Therapeutics, Inc. (NASDAQ:PTCT) Forecasts

PTC Therapeutics (PTCT) Up as EC Returns CHMP Opinion on DMD Drug
PTCT

Zacks

6 months ago

PTC Therapeutics (PTCT) Up as EC Returns CHMP Opinion on DMD Drug

PTCT

MT Newswires

6 months ago

Goldman Sachs Adjusts PTC Therapeutics Price Target to $32 From $18, Maintains Sell Rating

PTC Therapeutics Stock Soars As Its Biggest Drug 'Lives To Fight Another Day'
PTCT

Investor's Business Daily

6 months ago

PTC Therapeutics Stock Soars As Its Biggest Drug 'Lives To Fight Another Day'

PTCT

MT Newswires

6 months ago

Raymond James Upgrades PTC Therapeutics to Market Perform From Underperform

PTCT

MT Newswires

6 months ago

Sector Update: Health Care

PTCT

MT Newswires

6 months ago

PTC Therapeutics Says European Commission Seeking Review of Negative Opinion on Translarna

European Commission, in ‘unprecedented’ move, declines to revoke approval of PTC Duchenne drug
PTCT

BioPharma Dive

6 months ago

European Commission, in ‘unprecedented’ move, declines to revoke approval of PTC Duchenne drug

PTC Therapeutics Announces European Commission Returns Translarna™ Opinion to CHMP For Re-evaluation
PTCT

PR Newswire

6 months ago

PTC Therapeutics Announces European Commission Returns Translarna™ Opinion to CHMP For Re-evaluation

PTCT

MT Newswires

6 months ago

Sector Update: Health Care Stocks Steady Premarket Tuesday

PTCT

MT Newswires

6 months ago

Sector Update: Health Care

PTCT

MT Newswires

6 months ago

PTC Therapeutics Gets FDA Priority Review for Upstaza Biologics License Application

PTC Therapeutics Announces FDA Acceptance and Priority Review of the BLA for Upstaza™
PTCT

PR Newswire

6 months ago

PTC Therapeutics Announces FDA Acceptance and Priority Review of the BLA for Upstaza™

PTC Therapeutics to Participate at Upcoming Investor Conferences
PTCT

PR Newswire

7 months ago

PTC Therapeutics to Participate at Upcoming Investor Conferences

PTC Therapeutics Stock Sees IBD RS Rating Climb To 72
PTCT

Investor's Business Daily

7 months ago

PTC Therapeutics Stock Sees IBD RS Rating Climb To 72

PTC Therapeutics, Inc. (NASDAQ:PTCT) Q1 2024 Earnings Call Transcript
PTCT

Insider Monkey

7 months ago

PTC Therapeutics, Inc. (NASDAQ:PTCT) Q1 2024 Earnings Call Transcript

PTCT

MT Newswires

7 months ago

Morgan Stanley Upgrades PTC Therapeutics to Equalweight From Underweight, Adjusts PT to $30 From $28

Industry Analysts Just Made A Captivating Upgrade To Their PTC Therapeutics, Inc. (NASDAQ:PTCT) Revenue Forecasts
PTCT

Simply Wall St.

7 months ago

Industry Analysts Just Made A Captivating Upgrade To Their PTC Therapeutics, Inc. (NASDAQ:PTCT) Revenue Forecasts

PTC Therapeutics First Quarter 2024 Earnings: Beats Expectations
PTCT

Simply Wall St.

7 months ago

PTC Therapeutics First Quarter 2024 Earnings: Beats Expectations

Share on Social Networks: